Fact CheckerSign in

NCT05383755Completed

Digital Intervention to Address Stigma Among Pregnant Adolescents Living With HIV

Development of a Digital Intervention to Address Stigma Among Pregnant Unmarried Adolescents Living With HIV

Source: ClinicalTrials.gov · Last updated 12 Feb 2026

Brief summary (registry, in English)

Pregnant adolescents living with HIV (ALHIV) in Kenya frequently experience stigma and difficulty telling a family member about their HIV and pregnancy status. This study will develop and evaluate a digital intervention for pregnant unmarried ALHIV to address the effects of stigma and strengthen communication skills. Family caregivers are an important yet underappreciated and understudied source of social support for pregnant unmarried ALHIV. The study will also identify acceptable approaches to involve family caregivers in addressing the detrimental effects of the intersecting stigmas faced by pregnant ALHIV. Together, these approaches are expected to improve engagement in PMTCT services among pregnant ALHIV. The study specific aims are to: (1) Develop and evaluate a digital intervention for pregnant unmarried ALHIV aged 15-19 to increase awareness of stigma and its consequences; improve disclosure self-efficacy and skills; and facilitate enlistment of family caregivers as social support allies to enhance uptake of PMTCT services; and (2) Identify acceptable approaches to increase awareness about stigma and enhance skills in communication and provision of social support among family caregivers. We will use data from individual interviews with pregnant ALHIV and joint interviews with pregnant ALHIV/caregiver dyads to develop initial intervention specifications and mock-ups. We will then conduct focus groups to obtain feedback on sample materials in order to refine the materials and develop an intervention prototype. We will then conduct a pilot to evaluate acceptability, usability, and preliminary efficacy of the prototype. All participating adolescents will receive a session in using the digital intervention with a mobile phone or tablet. The research team will ask questions both before the session and two weeks after the session in order to assess the intervention's usability and acceptability and preliminary improvements in the adolescents regarding stigma, disclosure, and social support. We will conduct focus groups with caregivers to identify acceptable approaches to involve them. Data will be used to finalize content and specifications of the digital intervention for pregnant ALHIV and will provide the framework for a future complementary intervention for caregivers, which will both be tested in a larger R34 or R01 trial.

Status (registry)
Completed
Study type
Interventional
Enrollment
169 (actual)
First submitted
12 May 2022
Start date
30 Mar 2022
Primary completion date
14 Dec 2023
Lead sponsor
Pacific Institute for Research and Evaluation
Diseases
HIV
NCT number
NCT05383755

What you commit to

  • Study type: Interventional
  • Participants enrolled: 169
  • From 30 Mar 2022 to the primary completion date, 14 Dec 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Participated in a prior study activity

Other

  • Does not meet all inclusion criteria
  • Does not show adequate understanding of consent

Who the study is looking for

  • Female
  • Living with HIV
  • Pregnant
  • Unmarried
  • 15-19 years old

Age in the registry: 15 years to 19 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The Kenya Medical Research Institute - Centre for Global Health Research
Coordinator of this site? Confirm its status
KisumuKenyaUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.